2025 HFM Symposium - Managing Hyperkalemia in Heart Failure: Implementing Strategies to Reduce Patient Risk

This CME Symposium takes place on Friday, July 18, 2025, from 12:30 PM - 1:30 PM ET during the 2025 Heart Failure Management Conference at the Omni Amelia Island in Fernandina Beach, Florida.
By: CMEPlanet
 
CME Program at the 2025 HCM Conference
CME Program at the 2025 HCM Conference
HAZLET, N.J. - June 9, 2025 - PRLog -- In this symposium, attendees will be provided with best practices by a multidisciplinary faculty on the prevention of hyperkalemia, identification of patients at risk for hyperkalemia, the importance of maintaining HF patients on RAASi's and preferably at target doses, recent clinical evidence with novel potassium binders, and strategies for effective communication with patients.

Click here for more information

CHAIR

Akshay Desai, MD, MPH

Professor of Medicine
Harvard Medical School
Cardiovascular Division
Brigham and Women's Hospital
Boston, Massachusetts

FACULTY

Nancy Albert, PhD, CCNS, CHFN, CCRN, NE-BC

Associate Chief Nursing Officer--Research and Innovation
Clinical Nurse Specialist--Kaufman Center for Heart Failure
Cleveland Clinic
Cleveland, Ohio

Stephen Greene, MD
Associate Professor of Medicine
Duke University School of Medicine
Duke Clinical Research Institute
Durham, North Carolina

Robert Page, PharmD, MSPH, BCPS, BCGP
Professor, Departments of Clinical Pharmacy and Physical Medicine
Skaggs School of Pharmacy and Pharmaceutical Sciences
CU Anschutz
Aurora, Colorado

Educational Objectives
- Identify HF patients at risk for hyperkalemia
- Explain the relationship between down-titration or discontinuation of RAASi therapy and clinical outcomes
- Describe the clinical profi les of novel potassium binders
- Interpret the evidence with novel potassium binders for lowering potassium levels and reducing the risk of down-titration of mineralocorticoid receptor antagonist (MRA) therapy

Target Audience
This educational activity is intended for clinicians who manage patients with heart failure.

Educational Grant
Voxmedia International gratefully acknowledges the educational grant provided by AstraZeneca Pharmaceuticals.

Accreditation and Credit Designation Statements
Voxmedia, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Voxmedia, LLC designates this live activity for a maximum of 1.0 AMA PRA Category Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nurse practitioners may participate in this educational activity and earn a certificate of completion as AANP accepts AMA PRA Category 1 Credits™ through its reciprocity agreements. The National Commission on Certification of Physician Assistants accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.

End
Source:CMEPlanet
Email:***@voxmedia.us Email Verified
Tags:Cme, Hfmc, Hyperkalemia, Heartfailure, Patientrisk, Hfm2025, Meded, #cmeplanet
Industry:Event, Education, Medical
Location:Hazlet - New Jersey - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse



Like PRLog?
9K2K1K
Click to Share